PHILADELPHIA–May. 18, 2009– At the 109th General Meeting of the American Society for Microbiology, Bruker Daltonics announced collaborations in the United States for the clinical validation of its MALDI Biotyper workflow for microorganism identification. The MALDI Biotyper has recently obtained the IVD-CE Mark, and is currently for Research Use Only (RUO) outside of the European […]
Fully Automated, Integrated BD MAX(TM) System for Rapid Testing for Infectious Diseases Incorporates the New HandyLab Automated PCR System FRANKLIN LAKES, N.J. and ANN ARBOR, Mich., May 18 — BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX – News), and HandyLab, Inc. announced today that they have entered into an exclusive […]
HELSINKI, Finland–May. 16, 2009– At the 19th European Congress of Clinical Microbiology and Infectious Disease (ECCMID) opening here today, Bruker Daltonics announces that its MALDI Biotyper workflow for microbial identification in clinical microbiology has successfully obtained an IVD-CE mark with a Declaration of Conformity in accordance with the European Union In Vitro Diagnostic Directive 98/79/EC. […]
HELSINKI, Finland–May. 16, 2009– At the 19th European Congress of Clinical Microbiology and Infectious Disease (ECCMID), Bruker Daltonics announces an exclusive distribution agreement for its MALDI Biotyper with Francisco Soria Melguizo S.A. in Spain. Francisco Soria Melguizo is one of the market leaders for clinical microbiology in Spain, providing products for microbial identification and antibiotics […]
Files Voluntary Chapter 11 Petition; Molecular and POC Businesses Remain Fully Operational SAN DIEGO–Nanogen, Inc. (Pink Sheets: NGEN), developer of molecular and rapid diagnostic products, today announced that it has executed an asset purchase agreement with The Elitech Group (“Elitech”), a privately held diagnostics company, to acquire substantially all of the assets of Nanogen. As […]
ORANGE COUNTY, Calif., May 13 — Beckman Coulter, Inc. (NYSE: BEC – News), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, today announced that the Federal Trade Commission has terminated its review under the Hart-Scott-Rodino Antitrust Improvement Act of 1976, as amended, of the company’s pending acquisition […]
Palo Alto, CA and London, U.K. – May 11, 2009 — Nanosys Inc. and QuantuMDx Group (QMDx) today announced that QMDx has signed a non-exclusive license agreement with Nanosys for several patents and patent applications related to the use of nanowires for biosensors. The core intellectual property involves the use of nanowire-based field effect transistors […]
Collaboration with Noted Neurologists to Plan Next Clinical Studies OMAHA, Neb. and HOUSTON, May 11 — Transgenomic, Inc. (OTC Bulletin Board: TBIO – News) and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM – News), announced the clinical introduction of the NuroPro® AD and NuroPro® PD tests for Alzheimer’s and Parkinson’s disease at the 2009 […]
Companies to Publish Whitepaper, “An Integrated Sensor System for the Detection of Bio-Threats from Pandemics to Emerging Diseases to Bio-Terrorism,” Available May 7, 2009 at www.verichipcorp.com DELRAY BEACH, Fla. & CHASKA, Minn.–VeriChip Corporation (“VeriChip”) (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to […]
Company Working Directly with U.S. Centers for Disease Control, Association of Public Health Laboratories and International Agencies CARLSBAD, Calif.–Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced that it is helping to accelerate detection of Influenza A (H1N1) by providing instrument systems and other components to public health laboratories across the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
